Description

Worldwide Healthcare Trust PLC (WWH.L) operates as a closed-ended equity investment fund, established by Frostrow Capital LLP. OrbiMed Capital LLC is responsible for managing its investments, which span public stock markets across the globe. Specifically, it targets companies within the healthcare industry, giving particular attention to pharmaceutical and biotechnology firms. The trust primarily allocates capital to growth-oriented large-capitalization companies, specifically those with a market value of at least $5 billion. Portfolio construction is guided by fundamental analysis and a bottom-up stock selection methodology, with investment decisions supported by proprietary internal research. Its performance is measured against the MSCI World Healthcare Index. Established in April 1995 and domiciled in the United Kingdom, it was previously known as Finsbury Worldwide Pharmaceutical Trust plc.